Societe Generale’s Idexx Laboratories IDXX Stock Holding History

Societe Generale’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$5.91M	Buy	+63,655	New	+$5.47M	0.04%	351

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Societe Generale's IDXX Position: Q2 2016 in Review

Societe Generale opened a new position in Idexx Laboratories (IDXX) in Q2 2016: 63,655 shares worth $5.91M. The stake represents 0.04% of the portfolio and ranks #351 among its holdings.

437 funds tracked by Wall St. Rank hold IDXX as of Q2 2016.

Societe Generale held 63,655 shares of Idexx Laboratories worth $5.91M as of Q2 2016.
Idexx Laboratories was a new Societe Generale position in Q2 2016.
Idexx Laboratories made up 0.04% of Societe Generale's portfolio in Q2 2016, its #351 holding.
437 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2016.

Based on Societe Generale's 13F filing for Q2 2016, filed 2 Aug 2016.